Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of canakinumab with platinum-based chemotherapy in cancer (Japan)
jRCT2080224177Phase 1Completed
- Start
- Dec 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 1 trial of canakinumab in cancer. Started Dec 2018; status: completed.
02
Drugs
canakinumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224177.